Literature DB >> 23149096

An evaluation of the first time performance of international medical graduates in the MRCOG Part 1 and Part 2 written examinations.

S Rushd1, A B Landau, S W Lindow.   

Abstract

OBJECTIVES: To evaluate the performance of international medical graduates in the MRCOG Part 1 and Part 2 written examinations. STUDY
DESIGN: Using the database of the Royal College of Obstetricians and Gynaecologists, a retrospective analysis was performed of the performance of overseas candidates who appeared for the first time in the Part 1 (n=11,863) and Part 2 written (n=5336) MRCOG examinations between 2000 and 2010. Candidates were grouped according to the RCOG geographical bands.
RESULTS: In the Part 1 MRCOG examination the graduates of band E (India and Pakistan) and band B (Australia, New Zealand and Canada) performed well (pass rate 41.2% and 39.3% respectively) but the candidates of band C (East Africa 27.1%) and bands J and A (Europe 29.9%, Ireland 17.9%) underperformed. In the MRCOG Part 2 written examination the medical graduates of band D (Singapore and Hong Kong) and band B (Australia, New Zealand and Canada) performed well (pass rates 65.9% and 54.8%), but the candidates of band H (Middle East, pass rate 8.5%) and band C (Africa West, pass rate 12.7%) performed worse than the remaining cohort. The greatest number of candidates in the Part 2 written examinations appeared from India and Pakistan (n=2999, pass rate 22.2%).
CONCLUSION: Our results have shown that there is variation in performance among the IMG from different geographical regions in the Part 1 and Part 2 written MRCOG examinations.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 23149096     DOI: 10.1016/j.ejogrb.2012.10.004

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  PLAB and UK graduates' performance on MRCP(UK) and MRCGP examinations: data linkage study.

Authors:  I C McManus; Richard Wakeford
Journal:  BMJ       Date:  2014-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.